These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses. Bogdan JR; Morley PS; Townsend HG; Haines DM Can J Vet Res; 1993 Apr; 57(2):126-30. PubMed ID: 8387870 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus. Webster RG; Thomas TL Vaccine; 1993; 11(10):987-93. PubMed ID: 8212831 [TBL] [Abstract][Full Text] [Related]
7. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study. Gildea S; Arkins S; Walsh C; Cullinane A Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776 [TBL] [Abstract][Full Text] [Related]
8. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine. Heldens JG; Kersten AJ; Weststrate MW; van den Hoven R Vet Q; 2001 Nov; 23(4):210-7. PubMed ID: 11765243 [TBL] [Abstract][Full Text] [Related]
9. Is there a benefit from an early booster vaccination in the control of equine influenza? Heldens JG; van Loon AA; van de Zande S Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150 [TBL] [Abstract][Full Text] [Related]
10. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S; Süss J; Oehring H; Schmidt J Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [TBL] [Abstract][Full Text] [Related]
11. Serological investigation of racehorse vaccination against equine influenza in Morocco. Dilai M; Piro M; Fougerolle S; El Harrak M; Mahir W; El Mourid R; Legrand L; Paillot R; Fassi Fihri O Vet Microbiol; 2018 Sep; 223():153-159. PubMed ID: 30173741 [TBL] [Abstract][Full Text] [Related]
12. Studies on the antigenicity of an inactivated, aluminum hydroxide adjuvant equine influenza vaccine. Kucera CJ; Beckenhauer WH Can J Comp Med; 1977 Jul; 41(3):326-31. PubMed ID: 20211 [TBL] [Abstract][Full Text] [Related]
13. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Nicholson KG; Colegate AE; Podda A; Stephenson I; Wood J; Ypma E; Zambon MC Lancet; 2001 Jun; 357(9272):1937-43. PubMed ID: 11425416 [TBL] [Abstract][Full Text] [Related]
14. Comparative measurement of equine influenza virus antibodies in horse sera by single radial hemolysis, neutralization, and hemagglutination inhibition tests. Yamagishi H; Nagamine T; Shimoda K; Ide S; Igarashi Y; Yoshioka I; Matumoto M J Clin Microbiol; 1982 Apr; 15(4):660-2. PubMed ID: 7040463 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95). Heldens JG; Pouwels HG; van Loon AA Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389 [TBL] [Abstract][Full Text] [Related]
16. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza. van Maanen C; Bruin G; de Boer-Luijtze E; Smolders G; de Boer GF Vet Q; 1992 Jan; 14(1):13-7. PubMed ID: 1574831 [TBL] [Abstract][Full Text] [Related]
17. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host. Paillot R; Grimmett H; Elton D; Daly JM Vet Res; 2008; 39(3):21. PubMed ID: 18252187 [TBL] [Abstract][Full Text] [Related]